Skip to main content

Outset Medical to Present at 42nd Annual Cowen Health Care Conference

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the 42nd Annual Cowen Health Care Conference on Tuesday, March 8, 2022 at 11:50am PT / 2:50pm ET.

A live and archived webcast of the fireside chat will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.76
+1.54 (0.66%)
AAPL  281.06
+2.21 (0.79%)
AMD  220.00
+2.47 (1.13%)
BAC  53.45
-0.20 (-0.36%)
GOOG  316.38
-3.74 (-1.17%)
META  641.56
-6.39 (-0.99%)
MSFT  488.74
-3.27 (-0.66%)
NVDA  179.38
+2.38 (1.34%)
ORCL  201.35
-0.60 (-0.30%)
TSLA  427.43
-2.74 (-0.64%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.